US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neurocrine Biosciences

126.46

-0.8500-0.67%

Volume:312.47K

Turnover:39.68M

Market Cap:12.52B

PE:42.76

High:128.38

Open:127.88

Low:125.55

Close:127.31

Loading ...

Overview Company News Filings

Neurocrine presents new data on patient-reported improvements with INGREZZA

Neurocrine Biosciences Inc. to Present New Data on INGREZZA® at American Association of Nurse Practitioners National Conference

S&P 500 Futures Up In Premarket Trading; Regencell Bioscience, EchoStar Lead

Neurocrine Biosciences Appoints Lewis Choi as Chief Information Officer

THOMSON REUTERS

Press Release: Neurocrine Biosciences Appoints Lewis Choi as Chief Information Officer

Neurocrine Biosciences Inc. Files Initial Statement of Beneficial Ownership for Sanjay Chandru Keswani, Chief Medical Officer

Neurocrine Biosciences' Ingrezza to Meet Fiscal 2025 Sales Outlook, RBC Capital Says

MT Newswires Live

Neurocrine Price Target Maintained With a $145.00/Share by RBC Capital

Neurocrine announces new data from Phase 4 KINECT-PRO study

Fate Therapeutics Appoints Matthew Abernethy, M.b.a., to Its Board of Directors

THOMSON REUTERS

Neurocrine Biosciences Announces Leadership Transition: Sanjay Keswani to Succeed Eiry Roberts as Chief Medical Officer in 2025

Director Kevin Charles Gorman Reports Disposal of Common Shares of Neurocrine Biosciences Inc

Neurocrine Biosciences Announces Promising Phase 2 Results for Schizophrenia Treatment NBI-1117568 at ASCP 2025 Annual Meeting

Neurocrine Biosciences Inc. Conducted Annual Stockholders Meeting

Neurocrine Biosciences Says Tardive Dyskinesia Treatment Improves Functional, Quality of Life Measures

MT Newswires Live

BRIEF-Neurocrine Reports Late Stage Data Of Crenessity

Neurocrine Biosciences Announces New Results From Exploratory Analyses of the Phase 3 Cahtalyst™ Pediatric Study Demonstrating Crenessity™ Reduces Glucocorticoid Dosing While Maintaining or Improving Androstenedione Across Patient Subgroups

THOMSON REUTERS

Neurocrine Biosciences Inc - Data Consistent Across All Patient Subgroups in Cahtalyst Study

THOMSON REUTERS

Director William H. Rastetter Reports Disposal of Common Shares in Neurocrine Biosciences Inc

Neurocrine Biosciences’ Earnings Call Highlights Growth Amid Challenges

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NBIX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NBIX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBIX\",,,,,undefined,":{"symbol":"NBIX","market":"US","secType":"STK","nameCN":"Neurocrine Biosciences","latestPrice":126.46,"timestamp":1750438996465,"preClose":127.31,"halted":0,"volume":312472,"delay":0,"floatShares":97783376,"shares":98965820,"eps":2.957321,"marketStatus":"Trading","change":-0.85,"latestTime":"06-20 13:03:23 EDT","open":127.88,"high":128.38,"low":125.55,"amount":39682856.597440004,"amplitude":0.022229,"askPrice":126.57,"askSize":109,"bidPrice":126.35,"bidSize":123,"shortable":3,"etf":0,"ttmEps":2.957321,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1750449600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":832824000000,"exchange":"NASDAQ","adjPreClose":127.31,"preHourTrading":{"tag":"盘前","latestPrice":127.2,"preClose":127.31,"latestTime":"09:27 EDT","volume":2092,"amount":268123.87868,"timestamp":1750426060600},"postHourTrading":{"tag":"盘后","latestPrice":127.31,"preClose":127.31,"latestTime":"16:46 EDT","volume":10234,"amount":1302865.61,"timestamp":1750279615072},"volumeRatio":0.746657,"impliedVol":0.2795,"impliedVolPercentile":0.056},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBIX\",,,,,undefined,":{"symbol":"NBIX","floatShares":97783376,"roa":"8.75%","roe":"12.43%","lyrEps":3.399402,"volumeRatio":0.746657,"shares":98965820,"dividePrice":0,"high":128.38,"amplitude":0.022229,"preClose":127.31,"low":125.55,"week52Low":84.23,"pbRate":"4.94","psRate":"5.19","week52High":157.9799,"institutionHeld":0.9508,"latestPrice":126.46,"committee":0.060345,"eps":2.957321,"divideRate":0,"volume":312472,"delay":0,"ttmEps":2.957321,"open":127.88,"prevYearClose":136.5,"prevWeekClose":124.39,"prevMonthClose":123.02,"prevQuarterClose":110.6,"fiveDayClose":125.01,"twentyDayClose":120.56,"sixtyDayClose":116.18},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NBIX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2544127815","title":"Neurocrine presents new data on patient-reported improvements with INGREZZA","url":"https://stock-news.laohu8.com/highlight/detail?id=2544127815","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544127815?lang=en_us&edition=fundamental","pubTime":"2025-06-20 20:35","pubTimestamp":1750422926,"startTime":"0","endTime":"0","summary":"Neurocrine (NBIX) Biosciences announced the presentation of new analyses from a Phase 4 randomized withdrawal study demonstrating significant patie...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurocrine-presents-new-data-on-patient-reported-improvements-with-ingrezza-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurocrine-presents-new-data-on-patient-reported-improvements-with-ingrezza-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","LU0154245756.USD","LU0109394709.USD","LU0823416689.USD","LU2065171311.SGD","LU0889565916.HKD","LU0154245673.USD","LU2065171402.SGD","NBIX","LU2065170008.USD","LU2065169927.USD","BK4139","LU2324357040.USD"],"gpt_icon":0},{"id":"2544122220","title":"Neurocrine Biosciences Inc. to Present New Data on INGREZZA® at American Association of Nurse Practitioners National Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2544122220","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544122220?lang=en_us&edition=fundamental","pubTime":"2025-06-20 20:30","pubTimestamp":1750422636,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences Inc. to Present New Data on INGREZZA at American Association of Nurse Practitioners National Conference. Neurocrine Biosciences, Inc. will present new analyses from a Phase 4 study at the 2025 American Association of Nurse Practitioners National Conference in San Diego. The presentation, scheduled for June 20, 2025, will highlight significant patient-reported improvements in health-related quality of life and functional measures among older adults with tardive dyskinesia treated with INGREZZA  capsules. Additional presentations will include real-world insights on tardive dyskinesia and long-term improvements with valbenazine.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250620:nNDL5xl0C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154245673.USD","LU0823416689.USD","LU2065170008.USD","LU2065169927.USD","NBIX","LU2065171311.SGD","LU2065171402.SGD","LU0889565916.HKD","LU0154245756.USD","BK4139","LU0320765992.SGD","LU2324357040.USD","LU0109394709.USD"],"gpt_icon":0},{"id":"2543671004","title":"S&P 500 Futures Up In Premarket Trading; Regencell Bioscience, EchoStar Lead","url":"https://stock-news.laohu8.com/highlight/detail?id=2543671004","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543671004?lang=en_us&edition=fundamental","pubTime":"2025-06-16 19:31","pubTimestamp":1750073460,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Barrons.com using technology from Automated Insights.With U.S. stock markets set to open in two hours, Regencell Bioscience Holdings Ltd.  was up 59.0% in pre-market trading, and EchoStar Corp.  was up 43.7%.Roku Inc. Cl A , Circle Internet Group Inc. , and Incyte Corp.  were all posting gains of at least 9%. In early trading, Neurocrine Biosciences Inc.  and Trade Desk Inc. Cl A  had posted declines, falling 3.5% and 2.8%, respectively.Meanwhile S&P 500 futures were up 0.48%, with futures for the Dow Jones Industrial Average rising 0.41%. The Cboe Volatility Index futures were up 15.46%.In commodities news, Brent crude oil futures were down 0.71%, while gold futures were down 0.36%. Bitcoin climbed 1.25% to $106,627.In afternoon trading, stocks in Europe are up, with the STOXX Europe 600 Index climbing 0.32% and the FTSE 100 Index climbing 0.47% from the previous close.U.S. stock markets open for trading at 9:30 a.m. ET.Data source: Dow Jone","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","TTD","INCY","LU0348723411.USD","BK4089","LU0109394709.USD","BK4023","LU0154245673.USD","BK4613","LU1861558580.USD","LU0154245756.USD","BK4108","LU1720051017.SGD","NBIX",".SPX","BK4100","BK4585","LU0823416689.USD","LU0320765992.SGD","SPY","BK4507","LU2324357040.USD","VOO","BK4009","ROKU","LU2065171311.SGD","BK4539","BK4139","LU1548497426.USD","LU2065170008.USD","BK4007","BK4532","LU1861559042.SGD","BK4548","BK4528","RGC","LU2065169927.USD","LU1720051108.HKD","LU2357305700.SGD","SATS","LU0889565916.HKD","BK4550","BK4524","BK4588"],"gpt_icon":1},{"id":"2542376623","title":"Neurocrine Biosciences Appoints Lewis Choi as Chief Information Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2542376623","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542376623?lang=en_us&edition=fundamental","pubTime":"2025-06-10 04:05","pubTimestamp":1749499502,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nTUA2FXQK4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0154245756.USD","LU0154245673.USD","LU2065171402.SGD","LU2065170008.USD","LU0109394709.USD","LU0320765992.SGD","LU0823416689.USD","BK4139","LU0889565916.HKD","NBIX","LU2065171311.SGD","LU2065169927.USD","LU2324357040.USD"],"gpt_icon":0},{"id":"2542633769","title":"Press Release: Neurocrine Biosciences Appoints Lewis Choi as Chief Information Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2542633769","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542633769?lang=en_us&edition=fundamental","pubTime":"2025-06-10 04:05","pubTimestamp":1749499500,"startTime":"0","endTime":"0","summary":"SAN DIEGO, June 9, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc.  today announced the appointment of Lewis Choi as Chief Information Officer, effective June 9, 2025. Choi, an accomplished leader with 25 years of experience in information technology and artificial intelligence, will be responsible for driving the vision and long-term strategic direction of the company's technology initiatives.\"Lewis is a proven global healthcare leader with a track record of utilizing technology to drive both cultural and technological change,\" said Matt Abernethy, Chief Financial Officer, Neurocrine Biosciences. \"As we launch CRENESSITY, grow INGREZZA, and advance our pipeline, he joins Neurocrine at an exciting time when advancements in technology will play a critical role in advancing our mission to help more patients.\"","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154245756.USD","LU2324357040.USD","LU2065170008.USD","NBIX","LU0109394709.USD","LU0320765992.SGD","LU2065171311.SGD","LU0823416689.USD","III","LU2065171402.SGD","BK4139","BK4134","LU0154245673.USD","LU0889565916.HKD","LU2065169927.USD"],"gpt_icon":0},{"id":"2541910220","title":"Neurocrine Biosciences Inc. Files Initial Statement of Beneficial Ownership for Sanjay Chandru Keswani, Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2541910220","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541910220?lang=en_us&edition=fundamental","pubTime":"2025-06-05 05:35","pubTimestamp":1749072910,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences Inc. Files Initial Statement of Beneficial Ownership for Sanjay Chandru Keswani, Chief Medical Officer. Neurocrine Biosciences Inc. has filed an initial statement of beneficial ownership. The statement identifies Sanjay Chandru Keswani as the beneficial owner, who serves as the Chief Medical Officer of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2025, and is solely responsible for the information contained there","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL3CsGQh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171311.SGD","LU0889565916.HKD","LU0154245673.USD","LU0109394709.USD","NBIX","LU0154245756.USD","LU2065171402.SGD","LU2065169927.USD","BK4139","LU0823416689.USD","LU2065170008.USD","LU2324357040.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2540979291","title":"Neurocrine Biosciences' Ingrezza to Meet Fiscal 2025 Sales Outlook, RBC Capital Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2540979291","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540979291?lang=en_us&edition=fundamental","pubTime":"2025-06-03 00:31","pubTimestamp":1748881872,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences'  Ingrezza should at least meet the company's fiscal 2025 sales guidance due to an expected re-acceleration in new patient starts and as payer-related headwinds are unlikely to have an impact in Q2 and Q3, RBC Capital Markets said in a Monday note.Ingrezza is a treatment for adults with tardive dyskinesia and for involuntary movements of Huntington's disease.The company said last month it expects Ingrezza fiscal 2025 sales of $2.5 billion to $2.6 billion.RBC said its formulary and prescription checks indicate \"some favorable updates and stable coverage into Q2/Q3.\"According to the investment firm, its checks reaffirmed a \"solid\" outlook for Ingrezza for the rest of 2025 with stabilizing coverage access.In addition, market uptake for the company's Crenessity drug serves as a potential catalyst that could sustain stock momentum, RBC said.RBC has an outperform rating on Neurocrine Biosciences, with a $145 price target.Price: 123.03, Change: +0.01, Percent Change: +0","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NBIX"],"gpt_icon":0},{"id":"2540794182","title":"Neurocrine Price Target Maintained With a $145.00/Share by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2540794182","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540794182?lang=en_us&edition=fundamental","pubTime":"2025-06-02 23:50","pubTimestamp":1748879400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NBIX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 02, 2025 11:50 ET (15:50 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBIX"],"gpt_icon":0},{"id":"2540798201","title":"Neurocrine announces new data from Phase 4 KINECT-PRO study","url":"https://stock-news.laohu8.com/highlight/detail?id=2540798201","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540798201?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:35","pubTimestamp":1748867732,"startTime":"0","endTime":"0","summary":"Neurocrine (NBIX) Biosciences announced new data from the Phase 4 KINECT-PRO open-label study demonstrating robust and sustained improvements in ph...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurocrine-announces-new-data-from-phase-4-kinect-pro-study-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurocrine-announces-new-data-from-phase-4-kinect-pro-study-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","LU2065171402.SGD","LU0154245756.USD","LU2324357040.USD","PRO","LU0889565916.HKD","NBIX","LU2065170008.USD","LU0320765992.SGD","LU2065171311.SGD","LU0823416689.USD","LU2065169927.USD","BK4023","BK4139","LU0154245673.USD"],"gpt_icon":0},{"id":"2539208878","title":"Fate Therapeutics Appoints Matthew Abernethy, M.b.a., to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2539208878","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539208878?lang=en_us&edition=fundamental","pubTime":"2025-05-31 04:30","pubTimestamp":1748637014,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nTUA6HL9CB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","LU0823416689.USD","NBIX","BK4139","LU2065170008.USD","LU2065171311.SGD","FATE","LU0889565916.HKD","LU0109394709.USD","LU2065169927.USD","LU0320765992.SGD","LU2065171402.SGD"],"gpt_icon":0},{"id":"2539154270","title":"Neurocrine Biosciences Announces Leadership Transition: Sanjay Keswani to Succeed Eiry Roberts as Chief Medical Officer in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2539154270","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539154270?lang=en_us&edition=fundamental","pubTime":"2025-05-31 04:05","pubTimestamp":1748635548,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences Announces Leadership Transition: Sanjay Keswani to Succeed Eiry Roberts as Chief Medical Officer in 2025. Neurocrine Biosciences Inc. has announced that Sanjay Keswani, M.D. will take over as Chief Medical Officer effective June 2, 2025, succeeding Eiry W. Roberts, M.D., who has held the position for the past seven years. Dr. Roberts will transition to a strategic advisory role, continuing her association with the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 30, 2025, and is s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nNDL5XYc8V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBIX","LU0889565916.HKD","LU0823416689.USD","LU2065171402.SGD","LU2324357040.USD","LU0109394709.USD","LU2065171311.SGD","LU2065170008.USD","LU2065169927.USD","BK4139","LU0320765992.SGD"],"gpt_icon":0},{"id":"2539913842","title":"Director Kevin Charles Gorman Reports Disposal of Common Shares of Neurocrine Biosciences Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2539913842","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539913842?lang=en_us&edition=fundamental","pubTime":"2025-05-30 06:15","pubTimestamp":1748556944,"startTime":"0","endTime":"0","summary":"Kevin Charles Gorman, a director at Neurocrine Biosciences Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nNDL5lt1sk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Director Kevin Charles Gorman Reports Disposal of Common Shares of Neurocrine Biosciences Inc","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0823416689.USD","LU2065171311.SGD","LU2065169927.USD","LU2065171402.SGD","BK4139","LU2324357040.USD","NBIX","LU0320765992.SGD","LU2065170008.USD","LU0109394709.USD"],"gpt_icon":0},{"id":"2539770406","title":"Neurocrine Biosciences Announces Promising Phase 2 Results for Schizophrenia Treatment NBI-1117568 at ASCP 2025 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2539770406","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539770406?lang=en_us&edition=fundamental","pubTime":"2025-05-29 04:05","pubTimestamp":1748462751,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences Announces Promising Phase 2 Results for Schizophrenia Treatment NBI-1117568 at ASCP 2025 Annual Meeting. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the original content used to generate this news brief via PR Newswire  on May 28, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nNDLyJKng:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","NBIX","BK4139","LU2065171311.SGD","LU2065169927.USD","LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD","LU2065170008.USD","LU2324357040.USD","LU0823416689.USD"],"gpt_icon":0},{"id":"2537924203","title":"Neurocrine Biosciences Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2537924203","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537924203?lang=en_us&edition=fundamental","pubTime":"2025-05-23 04:04","pubTimestamp":1747944279,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences Inc. held its Annual Meeting of Stockholders on May 21, 2025. During the meeting, stockholders voted on several proposals. The election of four Class II Directors was approved. The 2025 Equity Incentive Plan was approved. The Amended and Restated 2018 Employee Stock Purchase Plan was approved. The appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nNDL2rH8Gf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0320765992.SGD","LU2065171311.SGD","NBIX","LU2324357040.USD","LU2065170008.USD","LU0823416689.USD","LU2065169927.USD","LU2065171402.SGD","LU0109394709.USD","BK4139"],"gpt_icon":0},{"id":"2535397623","title":"Neurocrine Biosciences Says Tardive Dyskinesia Treatment Improves Functional, Quality of Life Measures","url":"https://stock-news.laohu8.com/highlight/detail?id=2535397623","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535397623?lang=en_us&edition=fundamental","pubTime":"2025-05-16 20:53","pubTimestamp":1747399983,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences  said Friday the phase 4 study of its Ingrezza treatment for patients with tardive dyskinesia showed improvements in functional and health-related quality of life measures.Patients with the movement disorder who received the treatment for eight weeks experienced significant improvements in measures such as mobility, self-case, usual activities, and pain/discomfort, the company said.In a separate analysis, patients who received the treatment also experienced improvements in Sheehan Disability Scale items, including work/school, social life, and family/home life, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LU0109394709.USD","LU2324357040.USD","LU2065169927.USD","NBIX","LU0823416689.USD","LU2065171402.SGD","LU2065170008.USD","LU0889565916.HKD","LU2065171311.SGD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2533074180","title":"BRIEF-Neurocrine Reports Late Stage Data Of Crenessity","url":"https://stock-news.laohu8.com/highlight/detail?id=2533074180","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533074180?lang=en_us&edition=fundamental","pubTime":"2025-05-08 21:04","pubTimestamp":1746709493,"startTime":"0","endTime":"0","summary":"BRIEF-Neurocrine Reports Late Stage Data Of CrenessityMay 8 (Reuters) - Neurocrine Biosciences Inc NBIX.O:NEUROCRINE BIOSCIENCES ANNOUNCES NEW RESULTS FROM EXPLORATORY ANALYSES OF THE PHASE 3 CAHTALYS","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nFWN3RG1JF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171311.SGD","LU0889565916.HKD","LU0109394709.USD","NBIX","LU2065171402.SGD","LU2065169927.USD","BK4139","LU0823416689.USD","LU2065170008.USD","LU2324357040.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2533822111","title":"Neurocrine Biosciences Announces New Results From Exploratory Analyses of the Phase 3 Cahtalyst™ Pediatric Study Demonstrating Crenessity™ Reduces Glucocorticoid Dosing While Maintaining or Improving Androstenedione Across Patient Subgroups","url":"https://stock-news.laohu8.com/highlight/detail?id=2533822111","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533822111?lang=en_us&edition=fundamental","pubTime":"2025-05-08 20:30","pubTimestamp":1746707441,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nFWN3RG1JF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","LU2065171311.SGD","NBIX","LU0889565916.HKD","BK4139","LU2065169927.USD","LU0109394709.USD","LU2065171402.SGD","LU2065170008.USD","LU2324357040.USD","LU0823416689.USD"],"gpt_icon":0},{"id":"2533244182","title":"Neurocrine Biosciences Inc - Data Consistent Across All Patient Subgroups in Cahtalyst Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2533244182","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533244182?lang=en_us&edition=fundamental","pubTime":"2025-05-08 20:30","pubTimestamp":1746707441,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nFWN3RG1JF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LU0320765992.SGD","LU2065171311.SGD","LU2065171402.SGD","NBIX","LU2324357040.USD","LU0109394709.USD","LU0823416689.USD","LU2065169927.USD","LU0889565916.HKD","LU2065170008.USD"],"gpt_icon":0},{"id":"2533992776","title":"Director William H. Rastetter Reports Disposal of Common Shares in Neurocrine Biosciences Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2533992776","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533992776?lang=en_us&edition=fundamental","pubTime":"2025-05-08 07:06","pubTimestamp":1746659167,"startTime":"0","endTime":"0","summary":"William H. Rastetter, a Director at Neurocrine Biosciences Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 07, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nNDL2X7411:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","NBIX","BK4139","LU2065171311.SGD","LU2065169927.USD","LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD","LU2065170008.USD","LU2324357040.USD","LU0823416689.USD"],"gpt_icon":0},{"id":"2533069723","title":"Neurocrine Biosciences’ Earnings Call Highlights Growth Amid Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2533069723","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533069723?lang=en_us&edition=fundamental","pubTime":"2025-05-07 08:09","pubTimestamp":1746576546,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences (($NBIX)) has held its Q1 earnings call. Read on for the main highlights of the call. Neurocrine Biosciences’ recent earning...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurocrine-biosciences-earnings-call-highlights-growth-amid-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurocrine-biosciences-earnings-call-highlights-growth-amid-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NBIX"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":196,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NBIX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-05","symbol":"NBIX","fiscalQuarterEnding":"2025/03","expectedEps":0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746417600000,"reportTimeType":"post","actualEps":0.08},{"market":"US","date":"2025-02-06","symbol":"NBIX","fiscalQuarterEnding":"2024/12","expectedEps":1.56,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1738818000000,"reportTimeType":"post","actualEps":1},{"market":"US","date":"2024-10-30","symbol":"NBIX","fiscalQuarterEnding":"2024/09","expectedEps":1.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730260800000,"reportTimeType":"pre","actualEps":1.24},{"market":"US","date":"2024-08-01","symbol":"NBIX","fiscalQuarterEnding":"2024/06","expectedEps":1.15,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"pre","actualEps":0.63},{"market":"US","date":"2024-05-01","symbol":"NBIX","fiscalQuarterEnding":"2024/03","expectedEps":1.04,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1714536000000,"reportTimeType":"pre","actualEps":0.42}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NBIX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NBIX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3462,"buy":0.5,"hold":0.1538,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":26,"updateTime":1746590400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NBIX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NBIX","date":"2025-06-18","current":40.414819,"percent":0.404549,"low":15.452095,"twenty":26.680493,"median":54.092022,"eighty":113.591967,"high":905.986584,"avg":103.769077,"sd":175.082104,"marketCap":12358851601},"quantilePoints":[{"date":"2020-06-26","current":68.588653,"twenty":-85.975998,"median":-50.521811,"eighty":264.609771,"marketCap":12105897173},{"date":"2020-07-02","current":65.963174,"twenty":-85.955472,"median":-50.372722,"eighty":264.609771,"marketCap":11642500219},{"date":"2020-07-10","current":68.236133,"twenty":-85.785889,"median":-50.132555,"eighty":264.609771,"marketCap":12043677542},{"date":"2020-07-17","current":68.672836,"twenty":-85.623376,"median":-49.948259,"eighty":264.609771,"marketCap":12120755592},{"date":"2020-07-24","current":65.873729,"twenty":-85.227519,"median":-49.703126,"eighty":264.609771,"marketCap":11626713149},{"date":"2020-07-31","current":63.327173,"twenty":-84.91567,"median":-49.467785,"eighty":264.609771,"marketCap":11177245963},{"date":"2020-08-07","current":52.414884,"twenty":-84.564123,"median":-49.335886,"eighty":264.609771,"marketCap":10734568315},{"date":"2020-08-14","current":52.087035,"twenty":-84.490725,"median":-49.027477,"eighty":264.609771,"marketCap":10667424808},{"date":"2020-08-21","current":51.504192,"twenty":-84.414156,"median":-48.599484,"eighty":264.609771,"marketCap":10548058571},{"date":"2020-08-28","current":52.055161,"twenty":-84.383616,"median":-48.427294,"eighty":264.609771,"marketCap":10660896967},{"date":"2020-09-04","current":50.115387,"twenty":-84.164648,"median":-48.297263,"eighty":264.609771,"marketCap":10263631212},{"date":"2020-09-11","current":45.71219,"twenty":-84.021232,"median":-48.111608,"eighty":264.609771,"marketCap":9361856600},{"date":"2020-09-18","current":46.285926,"twenty":-83.682042,"median":-47.881304,"eighty":264.609771,"marketCap":9479357738},{"date":"2020-09-25","current":44.48731,"twenty":-83.463658,"median":-47.607315,"eighty":264.609771,"marketCap":9111000994},{"date":"2020-10-02","current":43.075737,"twenty":-83.463658,"median":-47.501461,"eighty":264.609771,"marketCap":8821910891},{"date":"2020-10-09","current":47.547235,"twenty":-83.463658,"median":-47.244256,"eighty":264.609771,"marketCap":9737673734},{"date":"2020-10-16","current":46.677524,"twenty":-83.039861,"median":-46.798492,"eighty":264.609771,"marketCap":9559556928},{"date":"2020-10-23","current":45.083813,"twenty":-82.052389,"median":-46.535456,"eighty":264.609771,"marketCap":9233164876},{"date":"2020-10-30","current":44.928995,"twenty":-81.511414,"median":-46.178337,"eighty":264.609771,"marketCap":9201458220},{"date":"2020-11-06","current":43.868039,"twenty":-80.971335,"median":-45.857748,"eighty":264.609771,"marketCap":8984174368},{"date":"2020-11-13","current":92.00871,"twenty":-80.52487,"median":-45.670701,"eighty":264.609771,"marketCap":8593613492},{"date":"2020-11-20","current":89.02778,"twenty":-79.90576,"median":-45.354214,"eighty":264.609771,"marketCap":8315194617},{"date":"2020-11-27","current":95.589827,"twenty":-79.6114,"median":-44.789283,"eighty":264.609771,"marketCap":8928089860},{"date":"2020-12-04","current":96.56013,"twenty":-79.346554,"median":-44.606027,"eighty":264.609771,"marketCap":9018716139},{"date":"2020-12-11","current":90.238157,"twenty":-78.964538,"median":-44.452865,"eighty":264.609771,"marketCap":8428243892},{"date":"2020-12-18","current":101.461659,"twenty":-78.437014,"median":-44.344704,"eighty":264.609771,"marketCap":9476518988},{"date":"2020-12-24","current":97.700486,"twenty":-78.222461,"median":-44.198304,"eighty":264.609771,"marketCap":9125225373},{"date":"2020-12-31","current":95.879918,"twenty":-77.80504,"median":-44.134512,"eighty":264.609771,"marketCap":8955184315},{"date":"2021-01-08","current":112.10498,"twenty":-77.629297,"median":-44.073414,"eighty":264.609771,"marketCap":10470605176},{"date":"2021-01-15","current":107.723613,"twenty":-77.54001,"median":-43.670322,"eighty":264.609771,"marketCap":10061385486},{"date":"2021-01-22","current":116.946491,"twenty":-77.430808,"median":-43.464999,"eighty":264.609771,"marketCap":10922802277},{"date":"2021-01-29","current":109.784256,"twenty":-77.197706,"median":-42.778855,"eighty":264.609771,"marketCap":10253849541},{"date":"2021-02-05","current":26.640957,"twenty":-77.197706,"median":-42.474008,"eighty":264.609771,"marketCap":10850861829},{"date":"2021-02-12","current":26.317137,"twenty":-77.197706,"median":-42.17745,"eighty":264.609771,"marketCap":10718969894},{"date":"2021-02-19","current":26.118778,"twenty":-77.197706,"median":-42.062964,"eighty":264.609771,"marketCap":10638178359},{"date":"2021-02-26","current":25.258455,"twenty":-77.197706,"median":-41.584197,"eighty":264.609771,"marketCap":10287768563},{"date":"2021-03-05","current":21.503477,"twenty":-77.235212,"median":-41.157807,"eighty":264.839255,"marketCap":8758366023},{"date":"2021-03-12","current":22.386865,"twenty":-77.235212,"median":-40.711654,"eighty":264.839255,"marketCap":9118170183},{"date":"2021-03-19","current":21.27052,"twenty":-77.235212,"median":-40.499511,"eighty":264.839255,"marketCap":8663482941},{"date":"2021-03-26","current":22.802035,"twenty":-77.197706,"median":-40.21778,"eighty":264.609771,"marketCap":9287268744},{"date":"2021-04-01","current":22.645193,"twenty":-77.197706,"median":-40.046982,"eighty":264.609771,"marketCap":9223387066},{"date":"2021-04-09","current":21.531155,"twenty":-77.111586,"median":-39.534588,"eighty":264.839255,"marketCap":8769639260},{"date":"2021-04-16","current":22.416552,"twenty":-76.721508,"median":-39.218794,"eighty":264.839255,"marketCap":9130261672},{"date":"2021-04-23","current":22.451368,"twenty":-75.974265,"median":-38.968034,"eighty":264.839255,"marketCap":9144442033},{"date":"2021-04-30","current":21.931456,"twenty":-74.817508,"median":-38.74439,"eighty":264.839255,"marketCap":8932681978},{"date":"2021-05-07","current":21.41161,"twenty":-74.315581,"median":-38.555072,"eighty":264.839255,"marketCap":8607467020},{"date":"2021-05-14","current":22.248882,"twenty":-73.863213,"median":-38.496002,"eighty":264.839255,"marketCap":8944050748},{"date":"2021-05-21","current":22.571091,"twenty":-73.160572,"median":-38.28134,"eighty":264.839255,"marketCap":9073578756},{"date":"2021-05-28","current":22.629889,"twenty":-72.277254,"median":-38.009435,"eighty":264.839255,"marketCap":9097215254},{"date":"2021-06-04","current":22.199493,"twenty":-71.999066,"median":-37.801929,"eighty":264.839255,"marketCap":8924196090},{"date":"2021-06-11","current":23.19199,"twenty":-71.242038,"median":-37.604814,"eighty":264.839255,"marketCap":9323180172},{"date":"2021-06-18","current":23.641202,"twenty":-70.605258,"median":-37.435625,"eighty":264.839255,"marketCap":9503763015},{"date":"2021-06-25","current":23.587108,"twenty":-70.169335,"median":-37.262869,"eighty":264.839255,"marketCap":9482017437},{"date":"2021-07-02","current":23.19199,"twenty":-69.420808,"median":-37.098736,"eighty":264.839255,"marketCap":9323180172},{"date":"2021-07-09","current":23.29077,"twenty":-68.775295,"median":-36.410287,"eighty":264.839255,"marketCap":9362889488},{"date":"2021-07-16","current":22.340606,"twenty":-67.912494,"median":-36.154968,"eighty":264.839255,"marketCap":8980923685},{"date":"2021-07-23","current":23.170823,"twenty":-65.471686,"median":-35.92931,"eighty":264.839255,"marketCap":9314671033},{"date":"2021-07-30","current":21.92197,"twenty":-64.037727,"median":-35.475637,"eighty":264.839255,"marketCap":8812631821},{"date":"2021-08-06","current":23.245079,"twenty":-62.98807,"median":20.197999,"eighty":264.839255,"marketCap":8477480466},{"date":"2021-08-13","current":23.128296,"twenty":-60.309524,"median":20.991434,"eighty":264.839255,"marketCap":8434889574},{"date":"2021-08-20","current":23.81083,"twenty":-59.363602,"median":21.378926,"eighty":264.839255,"marketCap":8683809677},{"date":"2021-08-27","current":24.711359,"twenty":-58.891511,"median":21.503477,"eighty":264.839255,"marketCap":9012232778},{"date":"2021-09-03","current":24.880046,"twenty":-57.788755,"median":21.578659,"eighty":264.839255,"marketCap":9073752956},{"date":"2021-09-10","current":25.105828,"twenty":-57.393419,"median":21.731847,"eighty":264.839255,"marketCap":9156095347},{"date":"2021-09-17","current":25.043543,"twenty":-57.122936,"median":21.874823,"eighty":264.839255,"marketCap":9133380205},{"date":"2021-09-24","current":24.65167,"twenty":-56.515676,"median":21.983228,"eighty":264.839255,"marketCap":8990464100},{"date":"2021-10-01","current":26.330755,"twenty":-56.073302,"median":22.061434,"eighty":264.839255,"marketCap":9602826483},{"date":"2021-10-08","current":27.010694,"twenty":-54.272284,"median":22.130844,"eighty":264.839255,"marketCap":9850800122},{"date":"2021-10-15","current":27.130073,"twenty":-53.483205,"median":22.199493,"eighty":264.839255,"marketCap":9894337478},{"date":"2021-10-22","current":26.870554,"twenty":-53.14751,"median":22.365311,"eighty":264.839255,"marketCap":9799691051},{"date":"2021-10-29","current":27.355854,"twenty":-53.059611,"median":22.416552,"eighty":264.839255,"marketCap":9976679870},{"date":"2021-11-05","current":19.879776,"twenty":-52.91578,"median":22.430689,"eighty":264.839255,"marketCap":8842524454},{"date":"2021-11-12","current":18.76859,"twenty":-52.59512,"median":22.430689,"eighty":264.839255,"marketCap":8348268984},{"date":"2021-11-19","current":18.346297,"twenty":-52.419753,"median":22.430689,"eighty":264.839255,"marketCap":8160432931},{"date":"2021-11-26","current":18.551045,"twenty":-52.090504,"median":22.430689,"eighty":264.839255,"marketCap":8251504957},{"date":"2021-12-03","current":16.994105,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":7558978098},{"date":"2021-12-10","current":16.987707,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":7556132097},{"date":"2021-12-17","current":18.476398,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":8218301614},{"date":"2021-12-23","current":18.147947,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":8072206907},{"date":"2021-12-31","current":18.16501,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":8079796242},{"date":"2022-01-07","current":16.064207,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7145359316},{"date":"2022-01-14","current":16.712577,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7433754063},{"date":"2022-01-21","current":16.017286,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7124488644},{"date":"2022-01-28","current":16.364931,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7279121353},{"date":"2022-02-04","current":17.305493,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7697483470},{"date":"2022-02-11","current":90.557458,"twenty":-51.955042,"median":22.431842,"eighty":264.609771,"marketCap":8113948252},{"date":"2022-02-18","current":90.693144,"twenty":-51.955042,"median":22.522526,"eighty":264.609771,"marketCap":8126105713},{"date":"2022-02-25","current":94.45608,"twenty":-51.955042,"median":22.586516,"eighty":264.609771,"marketCap":8463264811},{"date":"2022-03-04","current":93.743886,"twenty":-51.955042,"median":22.661461,"eighty":264.609771,"marketCap":8399452213},{"date":"2022-03-11","current":94.91316,"twenty":-51.955042,"median":22.80063,"eighty":264.609771,"marketCap":8504219165},{"date":"2022-03-18","current":98.99499,"twenty":-51.908672,"median":22.903884,"eighty":264.609771,"marketCap":8869951067},{"date":"2022-03-25","current":99.622146,"twenty":-51.908672,"median":23.045631,"eighty":264.609771,"marketCap":8926144250},{"date":"2022-04-01","current":101.588652,"twenty":-51.908672,"median":23.1378,"eighty":264.609771,"marketCap":9102343214},{"date":"2022-04-08","current":106.372046,"twenty":-51.908672,"median":23.19199,"eighty":264.609771,"marketCap":9530935287},{"date":"2022-04-14","current":105.521665,"twenty":-51.879725,"median":23.286066,"eighty":264.609771,"marketCap":9454741141},{"date":"2022-04-22","current":99.794282,"twenty":-51.235376,"median":23.504791,"eighty":264.609771,"marketCap":8941567652},{"date":"2022-04-29","current":95.96752,"twenty":-50.869461,"median":23.733072,"eighty":264.609771,"marketCap":8598689764},{"date":"2022-05-06","current":106.411117,"twenty":-50.538701,"median":24.05378,"eighty":264.609771,"marketCap":7597753757},{"date":"2022-05-13","current":112.603765,"twenty":-50.513367,"median":24.270178,"eighty":264.609771,"marketCap":8039908807},{"date":"2022-05-20","current":115.361299,"twenty":-50.513367,"median":24.572517,"eighty":264.609771,"marketCap":8236796731},{"date":"2022-05-27","current":124.624471,"twenty":-50.513367,"median":24.659455,"eighty":264.609771,"marketCap":8898187232},{"date":"2022-06-03","current":127.890676,"twenty":-50.513367,"median":24.724335,"eighty":264.609771,"marketCap":9131394287},{"date":"2022-06-10","current":126.244188,"twenty":-50.513367,"median":24.885236,"eighty":264.609771,"marketCap":9013834993},{"date":"2022-06-17","current":124.865421,"twenty":-50.513367,"median":25.0449,"eighty":264.609771,"marketCap":8915391031},{"date":"2022-06-24","current":131.50492,"twenty":-50.518997,"median":25.258455,"eighty":264.839255,"marketCap":9389451274},{"date":"2022-07-01","current":132.856915,"twenty":-50.518997,"median":25.998572,"eighty":264.839255,"marketCap":9485983703},{"date":"2022-07-08","current":127.930835,"twenty":-50.518997,"median":26.276232,"eighty":264.839255,"marketCap":9134261587},{"date":"2022-07-15","current":127.395391,"twenty":-50.518997,"median":26.439753,"eighty":264.839255,"marketCap":9096030922},{"date":"2022-07-22","current":127.556024,"twenty":-50.518997,"median":26.634392,"eighty":264.839255,"marketCap":9107500121},{"date":"2022-07-29","current":126.003238,"twenty":-50.518997,"median":26.826436,"eighty":264.839255,"marketCap":8996631194},{"date":"2022-08-05","current":815.065239,"twenty":-50.518997,"median":26.995123,"eighty":267.473329,"marketCap":9943795914},{"date":"2022-08-12","current":828.064055,"twenty":-50.518997,"median":27.355854,"eighty":332.018448,"marketCap":10102381477},{"date":"2022-08-19","current":838.803881,"twenty":-50.518997,"median":43.704114,"eighty":339.430085,"marketCap":10233407347},{"date":"2022-08-26","current":822.106196,"twenty":-50.518997,"median":44.350706,"eighty":343.175456,"marketCap":10029695593},{"date":"2022-09-02","current":807.525119,"twenty":-50.518997,"median":44.8698,"eighty":348.23866,"marketCap":9851806456},{"date":"2022-09-09","current":834.962629,"twenty":-50.518997,"median":45.079259,"eighty":349.917301,"marketCap":10186544079},{"date":"2022-09-16","current":831.670128,"twenty":-50.518997,"median":45.502731,"eighty":362.813526,"marketCap":10146375564},{"date":"2022-09-23","current":811.366371,"twenty":-50.518997,"median":45.962631,"eighty":364.154541,"marketCap":9898669723},{"date":"2022-09-30","current":832.610843,"twenty":-50.518997,"median":46.285926,"eighty":365.308101,"marketCap":10157852283},{"date":"2022-10-07","current":848.602992,"twenty":-50.518997,"median":47.210279,"eighty":371.273896,"marketCap":10352956498},{"date":"2022-10-14","current":848.446206,"twenty":-50.518997,"median":49.327638,"eighty":378.797857,"marketCap":10351043711},{"date":"2022-10-21","current":869.690678,"twenty":-50.518997,"median":50.903135,"eighty":389.463975,"marketCap":10610226271},{"date":"2022-10-28","current":905.986584,"twenty":-50.518997,"median":51.513299,"eighty":431.928138,"marketCap":11053036327},{"date":"2022-11-04","current":201.221497,"twenty":-50.458475,"median":52.087035,"eighty":434.881702,"marketCap":11711091146},{"date":"2022-11-11","current":200.593816,"twenty":-50.126307,"median":52.792822,"eighty":434.881702,"marketCap":11674560078},{"date":"2022-11-18","current":198.47952,"twenty":-49.947556,"median":54.395533,"eighty":434.881702,"marketCap":11551508062},{"date":"2022-11-25","current":201.766589,"twenty":-49.629464,"median":57.560591,"eighty":434.881702,"marketCap":11742815494},{"date":"2022-12-02","current":209.463947,"twenty":-49.385812,"median":59.991394,"eighty":434.881702,"marketCap":12190801742},{"date":"2022-12-09","current":193.656283,"twenty":-48.929381,"median":62.264354,"eighty":434.881702,"marketCap":11270795649},{"date":"2022-12-16","current":193.573693,"twenty":-48.286719,"median":62.627396,"eighty":434.881702,"marketCap":11265988929},{"date":"2022-12-23","current":198.727289,"twenty":-40.846451,"median":63.253512,"eighty":434.881702,"marketCap":11565928220},{"date":"2022-12-30","current":197.290229,"twenty":-39.648276,"median":63.753352,"eighty":434.881702,"marketCap":11482291302},{"date":"2023-01-06","current":203.20365,"twenty":-39.648276,"median":64.910878,"eighty":434.881702,"marketCap":11826452411},{"date":"2023-01-13","current":180.028985,"twenty":-39.648276,"median":65.66327,"eighty":434.881702,"marketCap":10477686948},{"date":"2023-01-20","current":183.943736,"twenty":-39.648276,"median":66.031573,"eighty":434.881702,"marketCap":10705525447},{"date":"2023-01-27","current":178.806658,"twenty":-37.833689,"median":67.168053,"eighty":434.881702,"marketCap":10406547501},{"date":"2023-02-03","current":181.746851,"twenty":-35.951624,"median":67.783646,"eighty":434.881702,"marketCap":10577666711},{"date":"2023-02-10","current":64.510722,"twenty":15.966099,"median":67.783646,"eighty":434.881702,"marketCap":9966906536},{"date":"2023-02-17","current":64.729529,"twenty":16.188336,"median":67.783646,"eighty":434.881702,"marketCap":10000712304},{"date":"2023-02-24","current":64.0481,"twenty":16.573519,"median":67.783646,"eighty":434.881702,"marketCap":9895431481},{"date":"2023-03-03","current":63.254141,"twenty":16.938226,"median":67.783646,"eighty":434.881702,"marketCap":9772764834},{"date":"2023-03-10","current":59.897008,"twenty":17.137429,"median":67.783646,"eighty":434.881702,"marketCap":9254087752},{"date":"2023-03-17","current":58.921752,"twenty":17.302081,"median":67.783646,"eighty":434.881702,"marketCap":9103410611},{"date":"2023-03-24","current":60.672212,"twenty":17.624986,"median":67.783646,"eighty":434.881702,"marketCap":9373856762},{"date":"2023-03-31","current":63.279148,"twenty":17.970498,"median":67.68894,"eighty":434.086512,"marketCap":9776628351},{"date":"2023-04-06","current":63.898061,"twenty":18.054957,"median":67.68894,"eighty":434.086512,"marketCap":9872250383},{"date":"2023-04-14","current":64.873317,"twenty":18.158185,"median":67.783646,"eighty":434.881702,"marketCap":10022927524},{"date":"2023-04-21","current":65.367197,"twenty":18.484076,"median":67.783646,"eighty":434.881702,"marketCap":10099231974},{"date":"2023-04-28","current":63.70426,"twenty":18.731906,"median":67.783646,"eighty":434.881702,"marketCap":9842308130},{"date":"2023-05-05","current":146.11832,"twenty":19.078272,"median":68.588653,"eighty":434.881702,"marketCap":9351572473},{"date":"2023-05-12","current":149.137041,"twenty":19.909208,"median":69.22003,"eighty":434.881702,"marketCap":9544770653},{"date":"2023-05-19","current":144.639451,"twenty":20.507993,"median":87.443915,"eighty":434.881702,"marketCap":9256924881},{"date":"2023-05-26","current":140.538259,"twenty":21.155662,"median":90.238157,"eighty":434.881702,"marketCap":8994448566},{"date":"2023-06-02","current":139.028898,"twenty":21.398536,"median":90.937629,"eighty":434.881702,"marketCap":8897849477},{"date":"2023-06-09","current":143.358782,"twenty":21.506213,"median":91.668604,"eighty":434.881702,"marketCap":9174962017},{"date":"2023-06-16","current":147.658173,"twenty":21.60402,"median":92.617131,"eighty":434.881702,"marketCap":9450123060},{"date":"2023-06-23","current":149.18278,"twenty":21.770569,"median":93.488972,"eighty":435.676893,"marketCap":9547697898},{"date":"2023-06-30","current":144.060101,"twenty":21.895923,"median":94.02934,"eighty":436.472083,"marketCap":9219846442},{"date":"2023-07-07","current":143.922886,"twenty":21.989585,"median":94.91316,"eighty":436.472083,"marketCap":9211064707},{"date":"2023-07-14","current":146.407995,"twenty":22.061764,"median":95.529687,"eighty":436.472083,"marketCap":9370111693},{"date":"2023-07-21","current":149.274256,"twenty":22.130933,"median":95.839905,"eighty":436.472083,"marketCap":9553552388},{"date":"2023-07-28","current":154.366443,"twenty":22.209371,"median":96.635182,"eighty":436.472083,"marketCap":9879452347},{"date":"2023-08-04","current":57.179827,"twenty":22.369622,"median":96.794628,"eighty":436.472083,"marketCap":10086521560},{"date":"2023-08-11","current":57.938239,"twenty":22.419379,"median":96.794628,"eighty":436.472083,"marketCap":10220305417},{"date":"2023-08-18","current":57.738949,"twenty":22.500257,"median":96.794628,"eighty":436.472083,"marketCap":10185150535},{"date":"2023-08-25","current":59.27238,"twenty":22.577261,"median":96.794628,"eighty":436.472083,"marketCap":10455647821},{"date":"2023-09-01","current":60.279905,"twenty":22.655218,"median":96.794628,"eighty":436.472083,"marketCap":10633375280},{"date":"2023-09-08","current":60.052935,"twenty":22.776647,"median":96.794628,"eighty":436.472083,"marketCap":10593337776},{"date":"2023-09-15","current":62.986937,"twenty":22.862726,"median":96.982474,"eighty":437.267273,"marketCap":11110895761},{"date":"2023-09-22","current":62.616035,"twenty":22.973265,"median":96.982474,"eighty":437.267273,"marketCap":11045468619},{"date":"2023-09-29","current":63.750885,"twenty":23.123786,"median":96.982474,"eighty":437.267273,"marketCap":11245656142},{"date":"2023-10-06","current":63.828387,"twenty":23.187287,"median":96.982474,"eighty":437.267273,"marketCap":11259327485},{"date":"2023-10-13","current":61.580831,"twenty":23.281362,"median":96.982474,"eighty":437.267273,"marketCap":10862858538},{"date":"2023-10-20","current":61.519936,"twenty":23.429531,"median":96.982474,"eighty":437.267273,"marketCap":10852116768},{"date":"2023-10-27","current":59.742927,"twenty":23.646846,"median":97.20033,"eighty":438.237231,"marketCap":10538652404},{"date":"2023-11-03","current":58.32872,"twenty":23.985048,"median":97.20033,"eighty":438.237231,"marketCap":11140785548},{"date":"2023-11-10","current":57.690854,"twenty":23.985048,"median":95.96752,"eighty":392.709437,"marketCap":11018953164},{"date":"2023-11-17","current":55.952155,"twenty":23.985048,"median":95.589827,"eighty":383.351833,"marketCap":10686861664},{"date":"2023-11-24","current":57.701142,"twenty":23.985048,"median":95.489796,"eighty":377.211039,"marketCap":11020918202},{"date":"2023-12-01","current":59.974826,"twenty":23.985048,"median":94.859599,"eighty":367.477481,"marketCap":11455191702},{"date":"2023-12-08","current":61.728957,"twenty":24.007626,"median":93.696554,"eighty":365.084276,"marketCap":11790230760},{"date":"2023-12-15","current":62.423408,"twenty":24.007626,"median":93.180509,"eighty":363.965151,"marketCap":11922870856},{"date":"2023-12-22","current":62.32567,"twenty":24.007626,"median":91.967766,"eighty":361.900364,"marketCap":11904202990},{"date":"2023-12-29","current":67.979014,"twenty":23.985048,"median":91.60565,"eighty":350.289361,"marketCap":12983991624},{"date":"2024-01-05","current":68.714617,"twenty":23.96247,"median":91.018028,"eighty":348.300433,"marketCap":13124491874},{"date":"2024-01-12","current":67.171393,"twenty":23.96247,"median":90.125498,"eighty":344.013234,"marketCap":12829736105},{"date":"2024-01-19","current":70.34529,"twenty":23.939892,"median":87.443915,"eighty":339.611278,"marketCap":13435950470},{"date":"2024-01-26","current":72.536668,"twenty":23.96247,"median":71.993968,"eighty":332.715749,"marketCap":13854503662},{"date":"2024-02-02","current":73.277416,"twenty":23.96247,"median":71.906519,"eighty":313.773789,"marketCap":13995986431},{"date":"2024-02-09","current":52.891564,"twenty":23.96247,"median":70.886562,"eighty":261.06275,"marketCap":13207023489},{"date":"2024-02-16","current":53.400095,"twenty":23.96247,"median":69.696194,"eighty":257.160449,"marketCap":13334003660},{"date":"2024-02-23","current":53.149035,"twenty":23.96247,"median":68.840647,"eighty":255.027964,"marketCap":13271313941},{"date":"2024-03-01","current":51.965465,"twenty":23.985048,"median":68.588653,"eighty":248.779166,"marketCap":12975776696},{"date":"2024-03-08","current":53.930111,"twenty":23.985048,"median":68.148768,"eighty":244.412047,"marketCap":13466348621},{"date":"2024-03-15","current":55.456397,"twenty":23.985048,"median":67.762962,"eighty":240.453561,"marketCap":13847462308},{"date":"2024-03-22","current":57.281564,"twenty":23.985048,"median":67.173314,"eighty":238.312647,"marketCap":14303206612},{"date":"2024-03-28","current":54.926381,"twenty":23.985048,"median":66.336739,"eighty":235.829511,"marketCap":13715117346},{"date":"2024-04-05","current":54.838709,"twenty":23.96247,"median":65.960543,"eighty":230.641182,"marketCap":13693225698},{"date":"2024-04-12","current":54.753332,"twenty":23.96247,"median":65.52974,"eighty":224.225614,"marketCap":13671906957},{"date":"2024-04-19","current":53.387822,"twenty":23.96247,"median":65.224959,"eighty":214.926531,"marketCap":13330939072},{"date":"2024-04-26","current":55.490466,"twenty":23.985048,"median":65.016713,"eighty":211.299293,"marketCap":13855969266},{"date":"2024-05-03","current":38.063574,"twenty":24.176232,"median":64.926662,"eighty":209.711716,"marketCap":14072103451},{"date":"2024-05-10","current":38.017298,"twenty":24.502187,"median":64.926662,"eighty":209.711716,"marketCap":14054995122},{"date":"2024-05-17","current":38.629778,"twenty":24.632825,"median":64.926662,"eighty":209.711716,"marketCap":14281428883},{"date":"2024-05-24","current":38.248679,"twenty":24.716549,"median":64.926662,"eighty":209.711716,"marketCap":14140536765},{"date":"2024-05-31","current":37.200658,"twenty":24.820876,"median":64.926662,"eighty":209.711716,"marketCap":13753083441},{"date":"2024-06-07","current":36.223413,"twenty":24.997349,"median":64.926662,"eighty":209.711716,"marketCap":13391795796},{"date":"2024-06-14","current":37.091773,"twenty":25.132663,"median":64.971688,"eighty":209.794306,"marketCap":13712828551},{"date":"2024-06-21","current":36.495626,"twenty":25.611349,"median":65.016713,"eighty":209.876896,"marketCap":13492433023},{"date":"2024-06-28","current":36.560957,"twenty":26.148895,"median":65.029383,"eighty":211.299293,"marketCap":13516585958},{"date":"2024-07-05","current":37.628033,"twenty":26.322584,"median":65.029383,"eighty":211.299293,"marketCap":13911083888},{"date":"2024-07-12","current":39.879237,"twenty":26.601174,"median":65.029383,"eighty":211.299293,"marketCap":14743353755},{"date":"2024-07-15","current":40.131034,"twenty":26.615894,"median":65.029383,"eighty":211.299293,"marketCap":14836443190},{"date":"2024-08-02","current":45.591134,"twenty":26.86173,"median":65.123383,"eighty":209.546537,"marketCap":15464512534},{"date":"2024-08-09","current":43.679968,"twenty":26.86173,"median":64.926662,"eighty":203.758652,"marketCap":14816245015},{"date":"2024-08-16","current":43.989565,"twenty":26.86173,"median":64.824841,"eighty":201.969234,"marketCap":14921260314},{"date":"2024-08-23","current":45.418474,"twenty":26.86173,"median":64.529477,"eighty":201.100989,"marketCap":15405946309},{"date":"2024-08-30","current":38.232251,"twenty":26.86173,"median":64.341928,"eighty":199.724972,"marketCap":12968379659},{"date":"2024-09-06","current":36.082934,"twenty":26.86173,"median":64.216895,"eighty":198.7372,"marketCap":12239331141},{"date":"2024-09-13","current":36.103772,"twenty":26.86173,"median":63.998087,"eighty":198.373805,"marketCap":12246399478},{"date":"2024-09-20","current":35.859667,"twenty":26.86173,"median":63.828387,"eighty":196.979242,"marketCap":12163598954},{"date":"2024-09-27","current":34.511134,"twenty":26.86173,"median":63.679253,"eighty":196.20378,"marketCap":11706176546},{"date":"2024-10-04","current":33.305492,"twenty":26.86173,"median":63.327173,"eighty":193.88423,"marketCap":11297222738},{"date":"2024-10-11","current":33.463267,"twenty":26.86173,"median":63.274802,"eighty":189.672156,"marketCap":11350740150},{"date":"2024-10-18","current":35.264288,"twenty":26.86173,"median":63.195636,"eighty":182.652034,"marketCap":11961646456},{"date":"2024-10-25","current":34.389081,"twenty":26.86173,"median":62.986937,"eighty":181.026669,"marketCap":11664776284},{"date":"2024-10-31","current":32.619923,"twenty":26.86173,"median":62.892828,"eighty":179.513625,"marketCap":12588028444},{"date":"2024-11-08","current":32.528095,"twenty":26.852907,"median":62.621935,"eighty":178.558889,"marketCap":12552592025},{"date":"2024-11-15","current":32.238181,"twenty":26.852907,"median":62.553735,"eighty":154.18349,"marketCap":12440714189},{"date":"2024-11-22","current":32.795708,"twenty":26.852907,"median":62.388604,"eighty":149.95728,"marketCap":12655863875},{"date":"2024-11-29","current":33.254848,"twenty":26.852907,"median":62.257511,"eighty":149.213272,"marketCap":12833045969},{"date":"2024-12-06","current":33.168268,"twenty":26.852907,"median":61.886863,"eighty":148.618675,"marketCap":12799634488},{"date":"2024-12-13","current":33.265343,"twenty":26.852907,"median":61.550384,"eighty":147.743551,"marketCap":12837095845},{"date":"2024-12-20","current":35.40887,"twenty":26.852907,"median":61.259752,"eighty":146.444586,"marketCap":13664283108},{"date":"2024-12-27","current":36.476699,"twenty":26.852907,"median":61.063228,"eighty":145.764611,"marketCap":14076358036},{"date":"2025-01-03","current":36.169731,"twenty":26.852907,"median":60.907571,"eighty":144.785813,"marketCap":13957899150},{"date":"2025-01-10","current":36.392742,"twenty":26.844083,"median":60.680648,"eighty":144.044855,"marketCap":14043959024},{"date":"2025-01-17","current":37.234935,"twenty":26.844083,"median":60.329767,"eighty":143.386225,"marketCap":14368961609},{"date":"2025-01-24","current":38.719925,"twenty":26.844083,"median":60.247462,"eighty":142.678807,"marketCap":14942019125},{"date":"2025-01-31","current":40.218033,"twenty":26.844083,"median":59.974826,"eighty":141.016986,"marketCap":15520138987},{"date":"2025-02-07","current":44.648909,"twenty":26.844083,"median":59.754628,"eighty":137.028614,"marketCap":15238672574},{"date":"2025-02-14","current":34.141082,"twenty":26.844083,"median":59.521493,"eighty":131.55311,"marketCap":11652351200},{"date":"2025-02-21","current":33.919064,"twenty":26.844083,"median":59.27238,"eighty":130.444741,"marketCap":11576576519},{"date":"2025-02-28","current":34.328044,"twenty":26.844083,"median":59.040533,"eighty":129.095424,"marketCap":11716161457},{"date":"2025-03-07","current":32.91122,"twenty":26.83526,"median":58.73161,"eighty":127.751461,"marketCap":11232599351},{"date":"2025-03-14","current":31.839108,"twenty":26.83526,"median":58.3673,"eighty":127.30972,"marketCap":10866687407},{"date":"2025-03-21","current":32.154607,"twenty":26.83526,"median":57.889136,"eighty":126.142453,"marketCap":10974367216},{"date":"2025-03-28","current":33.302672,"twenty":26.83526,"median":57.695998,"eighty":125.695358,"marketCap":11366202078},{"date":"2025-04-04","current":30.054201,"twenty":26.83526,"median":57.273606,"eighty":124.678015,"marketCap":10257498857},{"date":"2025-04-11","current":26.501916,"twenty":26.750137,"median":56.720224,"eighty":122.876248,"marketCap":9045103969},{"date":"2025-04-17","current":29.242083,"twenty":26.695569,"median":56.384258,"eighty":119.27935,"marketCap":9980323052},{"date":"2025-04-25","current":30.658387,"twenty":26.680493,"median":56.257145,"eighty":115.693273,"marketCap":10463707627},{"date":"2025-05-02","current":30.898993,"twenty":26.680493,"median":56.044889,"eighty":114.003704,"marketCap":10545826362},{"date":"2025-05-09","current":38.032908,"twenty":26.680493,"median":55.948895,"eighty":113.591967,"marketCap":11630463166},{"date":"2025-05-16","current":38.922888,"twenty":26.680493,"median":55.567979,"eighty":113.591967,"marketCap":11902619171},{"date":"2025-05-23","current":38.550714,"twenty":26.680493,"median":55.400605,"eighty":113.591967,"marketCap":11788808478},{"date":"2025-05-30","current":40.019991,"twenty":26.680493,"median":55.045675,"eighty":113.591967,"marketCap":12238113301},{"date":"2025-06-06","current":40.327439,"twenty":26.680493,"median":54.834724,"eighty":113.591967,"marketCap":12332130830},{"date":"2025-06-13","current":40.456891,"twenty":26.680493,"median":54.478076,"eighty":113.591967,"marketCap":12371717158},{"date":"2025-06-18","current":40.414819,"twenty":26.680493,"median":54.092022,"eighty":113.591967,"marketCap":12358851601}],"updateTime":1750409006773}}}